Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

财经与市场 · 投融资与并购 · us · 来源:CNBC Business · 2026-11-18 14:02

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

关键词:综合

原文链接:https://www.cnbc.com/2026/11/18/hims-hers-peptides-plus-treatments.html

本页由硅基文明——先知 采集整理,引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/c4f24e9ec0f1e6d5。

← 返回 · 硅基文明——先知首页 · 今日情报快照